A.I. VALI
A.I. VALI builds AI software for real-time endoscopy documentation and pharmaceutical AI validation, combining computer vision, voice-to-text, and EMR integration for hospitals, endoscopy centers, pharma companies, CROs, and academic research institutions.
- Company typePrivate
- Founded2017
- HeadquartersToronto, Canada
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
A.I. VALI firmographics
Firmographics- Name
- A.I. VALI
- Legal name
- A.I. VALI Inc.
- Website
- https://ai-vali.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- A.I. VALI builds AI software for real-time endoscopy documentation and pharmaceutical AI validation, combining computer vision, voice-to-text, and EMR integration for hospitals, endoscopy centers, pharma companies, CROs, and academic research institutions.
- Ownership category
- akta.pro rank
A.I. VALI industry classification
Industry- Product category
- Medical Imaging AI Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)
- akta.pro secondary industry
- Medical Imaging AI (HDAAAEAH)
Keywords
Where A.I. VALI is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
A.I. VALI business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations
Revenue model
- AI Medical Imaging Solutions: Revenue generated from licensing and deploying AIDREA™ and AIVALInk™ platforms to healthcare providers, pharmaceutical companies, CROs, and research institutions. The platform serves both clinical and research applications with expansion capabilities.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
A.I. VALI product offering
Product offeringCore offering
A.I. VALI develops and sells AI-powered software platforms for real-time medical imaging analysis during endoscopic procedures. Its flagship product, AIDREA™, performs automated image capture, voice-to-text annotation, and standardized reporting with direct EMR integration, compatible with any scope system or CADe detection software. The AIVALInk™ companion platform extends the offering to pharmaceutical companies, CROs, and academic institutions for regulatory-compliant AI validation and clinical trial data exchange.
Product overview
A.I. VALI is a medical imaging AI company offering cutting-edge real-time AI solutions for clinical and research applications. The portfolio consists of AIDREA™ as the core product - an agnostic, modular AI platform that provides real-time analysis during endoscopy procedures with automated image capture, voice-to-text annotation, and EMR integration. AIVALInk™ serves as a companion cloud-based validation and communication platform for pharmaceutical companies, CROs, and healthcare systems, enabling secure data exchange and automated reporting. Scope Tracker is an upcoming module for GI endoscopy scope tracking with 3D model generation.
Differentiator
Problem solved
Functional benefit
Brands
- AIDREA: AI VALI's first agnostic, modular AI platform that provides accurate, reproducible, and affordable real-time data capture system with expansion capabilities for both clinical and research applications. Provides automatic real-time image capture, voice to text annotation, and standardized patient/procedure data capture with EMR interface.
- AIVALInk
- Scope Tracker
Quantifiable outcome
- Standardized colonoscopy reporting including bowel prep quality and withdrawal time metrics
- +2 more outcomes
Companies that use A.I. VALI
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
A.I. VALI technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability7 records
Feature4 records
A.I. VALI partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- MedstackcoreA.I. VALI partners with Medstack for cloud infrastructure and security services. Medstack provides HIPAA-compliant infrastructure with encryption, access control, and regular audits to prevent unauthorized access and breaches. The partnership includes data redundancy and disaster recovery capabilities ensuring safety of patient information. This collaboration enables A.I. VALI to offer a secure, compliant cloud-based communication platform for medical imaging and AI validation.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
A.I. VALI competitors and assessment
Company assessmentDirect peers
- Iterative Health: Iterative Health applies AI to GI endoscopy for polyp detection and clinical decision support. It is a direct comparable in GI AI for endoscopy, addressing the same clinical gastroenterology end market with computer-vision-driven workflow tools.
- Virgo Surgical Video Solutions: Virgo is a cloud-based video capture and AI analytics platform for endoscopy. It directly overlaps with AIDREA's real-time endoscopy video capture, annotation, and EMR integration use cases for clinical GI practices.
- Wision AI: Wision AI develops AI software for colonoscopy polyp detection and endoscopy workflow. It is a focused direct competitor in GI endoscopy AI, comparable to AIDREA's clinical decision-support capabilities.
- Satisfai Health: Satisfai Health builds AI tools for GI endoscopy including real-time analysis and quality metrics. It directly competes with AIDREA on AI-driven endoscopy workflow and quality measurement.
- AI Medical Service: AI Medical Service is a Japanese startup developing AI for endoscopic image diagnosis, including gastric and colorectal cancer detection. It is a comparable direct peer in AI-driven endoscopy diagnosis, particularly for Asian clinical markets.
- Magentiq Eye: Magentiq Eye provides AI-based real-time polyp detection and colonoscopy analysis software. It overlaps with AIDREA on real-time computer-vision analysis during endoscopic procedures.
Broad incumbents
- Medtronic (GI Genius): Medtronic's GI Genius is an AI-powered polyp detection module integrated with its endoscopy hardware. As a large diversified medtech incumbent, it competes in the same endoscopy AI category but with bundled hardware advantages and substantially greater scale.
- Olympus (EndoBRAIN / Odin Vision): Olympus sells EndoBRAIN AI for colonoscopy and acquired Odin Vision, a GI AI startup. It is a broad incumbent with deeply embedded scope hardware and a growing AI software portfolio that competes with AIDREA's agnostic positioning.
- Fujifilm (CAD EYE): Fujifilm offers CAD EYE, an AI-assisted detection system bundled with its endoscopy systems. It competes in the same colonoscopy AI category and shares the same clinical customers (gastroenterologists and endoscopy centers).
- Pentax Medical (HOYA): Pentax Medical, a division of HOYA, is a major endoscopy equipment manufacturer developing AI features for its systems. It competes broadly with A.I. VALI by bundling AI into its hardware platform across the same clinical GI end market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
A.I. VALI social profiles
Digital presenceA.I. VALI compliance and trust
Trust signalCompliance4 records
A.I. VALI financial estimates
Financial estimateRevenue estimate
Valuation estimate
A.I. VALI leadership team
Management profileNumber of profiles
Profiles1 record
A.I. VALI funding detail
Funding detailFunding overview
Funding rounds4 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
A.I. VALI M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about A.I. VALI
What does A.I. VALI do?
A.I. VALI develops and sells AI-powered software platforms for real-time medical imaging analysis during endoscopic procedures. Its flagship product, AIDREA™, performs automated image capture, voice-to-text annotation, and standardized reporting with direct EMR integration, compatible with any scope system or CADe detection software. The AIVALInk™ companion platform extends the offering to pharmaceutical companies, CROs, and academic institutions for regulatory-compliant AI validation and clinical trial data exchange.
Is A.I. VALI a public or private company?
A.I. VALI is a private company. It is classified as unknown and is currently operating.
When was A.I. VALI founded?
A.I. VALI was founded in 2017. It employs 1 to 10 people.
Where is A.I. VALI based?
A.I. VALI is headquartered in Toronto, Canada, in the North America region.
How does A.I. VALI make money?
One revenue line is on record: AI Medical Imaging Solutions.
Who are A.I. VALI's main competitors?
Direct peers on record are Iterative Health, Virgo Surgical Video Solutions, Wision AI, Satisfai Health, AI Medical Service and Magentiq Eye. Broad incumbents are Medtronic (GI Genius), Olympus (EndoBRAIN / Odin Vision), Fujifilm (CAD EYE) and Pentax Medical (HOYA).
Does A.I. VALI have an API?
No public API is recorded for A.I. VALI.
What industry is A.I. VALI in?
A.I. VALI's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software, with a secondary code of HDAAAEAH, Medical Imaging AI. Its NAICS code is 513210 and its SIC code is 7372.